Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TAK

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TAK

  • Market Cap$45.677bn
  • SymbolNYSE:TAK
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINUS8740602052

Company Profile

Takeda Pharmaceutical Co Ltd ("Takeda") is Japan's largest pharmaceutical company, with revenue of JPY 2.1 trillion in 2018. In January 2019, it closed its acquisition of Shire Plc ("Shire"), a diversified, Ireland-based specialty drug firm with $15 billion revenue in 2017, mostly derived from the U.S. In future, management intends to focus future R&D and sales efforts on five areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which comprise approximately 75% of revenue. Its geographic footprint will increase in the U.S. and diversify away from Japan, with pro-forma distribution expected to be about 48% U.S, 20% Japan, and 32% in the Rest of the World, or RoW.Takeda Pharmaceutical Co Ltd is a pharmaceutical company in Japan. It is primarily focused on four therapeutic areas; oncology, gastroenterology, cardiovascular/metabolic, and neurology. The company markets its products across Europe and emerging markets.

Latest TAK news

Currently there for this company. Visit our news hub for other news .